A Phase 1/2 Study to Evaluate CHM-2101, an Autologous Cadherin 17 Chimeric Antigen Receptor (CAR) T Cell Therapy

Clinical trial NCT06055439 · RECRUITING

Trial details

NCT number: NCT06055439
Sponsor: Chimeric Therapeutics
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Neuroendocrine Tumors Colorectal Cancer Gastric Cancer

Start date: 2024-05-15
Primary completion: 2026-05-01
Enrollment: 135

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.